INFINIMMUNE
Live / Applied — Third extension granted (statement of use) (as of 18 Dec 2025)
What this means for you
Not registered yet, but its 07 Mar 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97827376
- Mark type
- Stylized text
- Filed
- 07 Mar 2023
- Published for opposition
- 30 Apr 2024
- Attorney of record
- Aaron D. Hendelman
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations featuring antibodies for medical purposes for the treatment of autoimmune diseases, cardiovascular disease, central nervous system diseases and disorders, endocrine disorders, gastrointestinal diseases, genetic diseases and disorders, infectious diseases, inflammatory diseases, kidney disease, liver disease, metabolic diseases and disorders, musculoskeletal disorders, neurodegenerative diseases and disorders, neurological diseases and disorders, neuromuscular and viral diseases and disorders, blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations with protein expression for the treatment of autoimmune diseases, cardiovascular disease, central nervous system diseases and disorders, endocrine disorders, gastrointestinal diseases, genetic diseases and disorders, infectious diseases, inflammatory diseases, kidney disease, liver disease, metabolic diseases and disorders, musculoskeletal disorders, neurodegenerative diseases and disorders, neurological diseases and disorders, neuromuscular and viral diseases and disorders, blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes
- Class 009 — Scientific and electric apparatus: downloadable computer software for the visualization and analysis of biological data for biomolecular research and the design and engineering of biomolecular products; downloadable computer software in the field of drug design and development
- Class 042 — Scientific and technological services: medical research and development in the fields of immunology, single cell technologies, protein engineering, computational biology, genome assembly and DNA sequencing and scientific research and development; medical research and development and scientific research and development in the fields of immunology, single cell technologies, protein engineering, computational biology, genome assembly and DNA sequencing; pharmaceutical drug development services; providing temporary use of online non-downloadable software for the visualization and analysis of biological data for biomolecular research and the design and engineering of biomolecular products; providing temporary use of online non-downloadable software in the field of drug design and development
- Class 044 — Medical, beauty and agricultural services: providing medical services and medical information in the fields of immunology, single cell technologies, protein engineering, computational biology, genome assembly and DNA sequencing
Owner
- Infinimmune, Inc., Alameda, CA, US
- Infinimmune, Inc., Alameda, CA, US
Prosecution history
- 19 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Dec 2025 — SOU EXTENSION 3 GRANTED
- 18 Dec 2025 — SOU EXTENSION 3 FILED
- 18 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 15 Jul 2025 — ASSIGNED TO EXAMINER
- 25 Jun 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Jun 2025 — SOU EXTENSION 2 GRANTED
- 24 Jun 2025 — SOU EXTENSION 2 FILED
- 24 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 16 Dec 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Dec 2024 — SOU EXTENSION 1 GRANTED
- 12 Nov 2024 — SOU EXTENSION 1 FILED
- 12 Dec 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 12 Nov 2024 — SOU TEAS EXTENSION RECEIVED
- 25 Jun 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT